Autotaxin/Lysophosphatidic Acid Axis: From Bone Biology to Bone Disorders

International Journal of Molecular Sciences

Candide Alioli¹  Olivier Peyruchaud¹  Léa Demesmay¹  Irma Machuca-Gayet¹ 

[1] Univ Lyon, INSERM, Unit 1033, LYOS, F-69372 Lyon, France;

关键词: autotaxin;    lysophosphatidic acid;    GPCR;    bone;    osteoblast;    osteocyte;   

DOI  :  10.3390/ijms23073427

来源: DOAJ

【 摘 要 】

Lysophosphatidic acid (LPA) is a natural bioactive phospholipid with pleiotropic activities affecting multiple tissues, including bone. LPA exerts its biological functions by binding to G-protein coupled LPA receptors (LPA_1-6) to stimulate cell migration, proliferation, and survival. It is largely produced by autotaxin (ATX), a secreted enzyme with lysophospholipase D activity that converts lysophosphatidylcholine (LPC) into active LPA. Beyond its enzymatic activity, ATX serves as a docking molecule facilitating the efficient delivery of LPA to its specific cell surface receptors. Thus, LPA effects are the result of local production by ATX in a given tissue or cell type. As a consequence, the ATX/LPA axis should be considered as an entity to better understand their roles in physiology and pathophysiology and to propose novel therapeutic strategies. Herein, we provide not only an extensive overview of the relevance of the ATX/LPA axis in bone cell commitment and differentiation, skeletal development, and bone disorders, but also discuss new working hypotheses emerging from the interplay of ATX/LPA with well-established signaling pathways regulating bone mass.

【 授权许可】

Unknown